Chemoinformaics analysis of Sophoracoumestan A
Molecular Weight | 334.327 | nRot | 0 |
Heavy Atom Molecular Weight | 320.215 | nRig | 26 |
Exact Molecular Weight | 334.084 | nRing | 5 |
Solubility: LogS | -3.658 | nHRing | 3 |
Solubility: LogP | 2.021 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 4 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 17 |
No. of Oxygen atom | 5 | No. of Arom Bond | 20 |
nHA | 5 | APOL | 46.7451 |
nHD | 1 | BPOL | 20.1209 |
QED | 0.763 |
Synth | 3.752 |
Natural Product Likeliness | 1.515 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.276 |
Pgp-sub | 0.002 |
HIA | 0.002 |
CACO-2 | -4.847 |
MDCK | 0.0000459 |
BBB | 0.093 |
PPB | 0.942686 |
VDSS | 1.442 |
FU | 0.0375328 |
CYP1A2-inh | 0.056 |
CYP1A2-sub | 0.977 |
CYP2c19-inh | 0.548 |
CYP2c19-sub | 0.917 |
CYP2c9-inh | 0.088 |
CYP2c9-sub | 0.834 |
CYP2d6-inh | 0.106 |
CYP2d6-sub | 0.788 |
CYP3a4-inh | 0.911 |
CYP3a4-sub | 0.926 |
CL | 9.551 |
T12 | 0.153 |
hERG | 0.047 |
Ames | 0.099 |
ROA | 0.109 |
SkinSen | 0.052 |
Carcinogencity | 0.346 |
EI | 0.02 |
Respiratory | 0.516 |
NR-Aromatase | 0.335 |
Antiviral | Yes |
Prediction | 0.650349 |